Mark L. Smith serves as Executive at NABI BIOPHARMACEUTICALS, where they oversee executive responsibilities. Since joining the company, Mark L. Smith has executed 15 insider transactions totaling $59.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 17, 2013 involved selling 2,470 shares valued at $4.8K.
Mark L. Smith currently holds 158,440 shares of NABI BIOPHARMACEUTICALS (NABI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark L. Smith has been a net seller of NABI stock. They have purchased $0 and sold $59.6K worth of shares.
Mark L. Smith's most recent insider trade was on Sep 17, 2013, when they sold 2,470 shares at $1.95 per share.
Get notified when new Form 4 filings are submitted
| $1.74 |
| Discretionary |
| Aug 15, 2013 | GEVO | $635 | Sale | 351 | $1.81 | Discretionary |
| Jul 16, 2013 | GEVO | $4.9K | Sale | 2,470 | $1.97 | Discretionary |
| Jun 18, 2013 | GEVO | $28.0K | Sale | 12,709 | $2.20 | Discretionary |
| Jun 17, 2013 | GEVO | $597 | Sale | 351 | $1.70 | Discretionary |
| May 15, 2013 | GEVO | $569 | Sale | 351 | $1.62 | Discretionary |
| Apr 16, 2013 | GEVO | $672 | Sale | 352 | $1.91 | Discretionary |
| Mar 21, 2013 | GEVO | $0 | Award | 152,564 | $N/A | Discretionary |
| Mar 18, 2013 | GEVO | $670 | Sale | 351 | $1.91 | Discretionary |
| Feb 19, 2013 | GEVO | $849 | Sale | 351 | $2.42 | Discretionary |
| Jan 15, 2013 | GEVO | $663 | Sale | 351 | $1.89 | Discretionary |
| Aug 1, 2012 | GEVO | $13.6K | Sale | 3,513 | $3.88 | Discretionary |
| Mar 14, 2012 | GEVO | $0 | Award | 31,615 | $N/A | Discretionary |
| Nov 30, 2005 | NABI | $1.6K | Other | 594.31 | $2.64 | Discretionary |